August 26, 2022
Although further studies are needed to confirm the long-term effects, recent studies have shown the infliximab biosimilar to be a safe, effective, and cost reducing treatment for inflammatory bowel diseases.
August 10, 2022
The American Gastroenterological Association has released updated guidelines for treating irritable bowel syndrome with constipation (IBS-C).
August 08, 2022
Treatments, including some biosimilars, may soon be offering relief to patients.
June 24, 2022
Pharmacists who encounter patients with severe gastrointestinal complains may want to stay abreast of ongoing issues with the meal delivery service.
June 15, 2022
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
June 01, 2022
High-dose haloperidol and aprepitant were both associated with emergency department discharge.
May 26, 2022
Seniors prescribed multiple courses of antibiotics were at greater risk for IBD.
April 28, 2022
Patients taking high-risk antibiotics and a probiotic capsule had a lower risk of healthcare-associated C diff infections.
April 27, 2022
Reducing perioperative antibiotic use can mitigate this risk.
April 26, 2022
Concerns were raised about the effectiveness of the vaccine in patients on immunosuppressive therapies.
